Healthcare Finance News November 26, 2024
The proposed rule would need to become final under the Trump Administration.
On Tuesday, the Centers for Medicare and Medicaid Services announced a proposed rule for coverage of obesity drugs in Medicare and Medicaid, starting in 2026.
After notice and comment rulemaking, the rule would need to be finalized under the Trump Administration. Comments must be submitted no later than January 27, 2025.
An estimated 3.4 million people would be newly able to obtain coverage for obesity drugs under Medicare Part D, CMS estimated. The cost to the federal government over 10 years would be $25 billion.
CMS expects no short-term premium impact, said Dr. Meena Seshamani, deputy administrator and director, CMS, during a call with reporters on Tuesday morning.
...Today's Sponsors
Today's Sponsor